RAPT Therapeutics (RAPT) Financials

$58.01

$0.00 (0.00%)

As on 06-Mar-2026 09:30EDT

Market cap

$1,680 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

11.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	--	--	--	1.53	3.81	5.04
Cost of Revenue	0.20	3.54	3.55	2.81	1.00	--
Gross Profit	-0.20	-3.54	-3.55	1.53	3.81	5.04
Operating Expenses	112.44	136.10	127.06	87.32	73.02	58.26
Operating Profit (EBIT)	-112.64	-136.10	-127.06	-85.80	-69.21	-53.21
Other Income	--	--	--	1.96	0.01	1.31
Profit before Tax	-105.64	-129.87	-116.80	-83.84	-69.20	-51.90
Provision for Tax	--	--	--	-1.96	-1.00	0.99
Profit after Tax (Net Income)	-105.64	-129.87	-116.80	-81.88	-68.21	-52.89
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-83.84	-69.20	-52.89

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	151.98	189.90	147.04	245.17	186.38	104.18
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.39	2.07	4.46	6.82	2.66	3.05
Current Liabilities	13.38	48.35	21.84	14.22	9.60	11.74
Total Liabilities	179.11	240.33	173.33	266.21	198.64	118.97

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	4.69	5.09	11.55	13.52	5.66	3.37
Current Assets	161.05	235.24	161.78	252.69	192.97	115.60
Total Assets	179.11	240.33	173.33	266.21	198.64	118.97
Total Debt*	2.60	4.49	6.91	8.99	--	--
Net Current Assets	147.67	186.89	139.95	238.47	183.38	103.86

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-83.30	-97.05	-70.77	-61.03	-40.49
Cash Flow from Investing Activities	--	52.70	104.13	-45.49	-81.35	-87.44
Cash from Financing Activities	--	152.85	1.45	131.18	141.48	75.46
Net Cash Inflow / Outflow	--	--	--	14.92	-0.89	-52.47

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-11.07	-22.25	-24.34	-18.35	-18.47	-17.21
Cash EPS ($)	--	-22.05	-24.10	-18.12	-18.20	-16.85
Adjusted Book Value ($)	--	32.54	30.65	54.96	50.48	33.90
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-14.27	-20.23	-15.86	-16.53	-13.18
Free Cash Flow per Share ($)	--	-14.29	-20.46	-16.05	-16.73	-13.31

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-74.56	-57.24	-37.17	-46.95	-59.66
ROE (%)	-64.15	-77.09	-59.56	-37.95	-46.95	-59.66
ROA (%)	-70.91	-62.79	-53.15	-35.23	-42.95	-51.96
EBIT Margin (%)	--	--	--	-5,618.53	-1,815.08	-1,055.41
Net Margin (%)	--	--	--	-2,350.20	-1,786.49	-832.42
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	--	--	-1.00	-0.60	-0.24	4.39
EBIT Growth (%)	5.14	-7.11	-48.10	-23.97	-30.06	-21.97
Net Profit Growth (%)	1.73	-11.19	-42.64	-20.05	-28.96	-23.01
EPS Growth (%)	50.23	0.09	-0.33	0.01	-0.07	-0.13
Book Value Growth (%)	-71.30	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.07	-1.02	-1.08	-1.99	-1.15
Price / Book Value	11.05	0.05	0.81	0.36	0.73	0.58
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-10.73	1.61	0.26	1.79	0.79	0.98
Close Price ($)	25.79	12.64	198.80	158.40	293.84	158.00
High Price ($)	27.74	218.80	251.60	325.92	346.08	409.68
Low Price ($)	5.67	6.31	83.76	78.84	119.12	84.16
Market Cap ($ Cr)	1,680.29	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.02	0.05	0.04	--	--
Short term debt to equity ratio	0.01	0.01	0.02	0.01	0.03	0.05
Current Ratio	12.04	4.87	7.41	17.77	20.11	9.84
Quick Ratio	12.04	--	--	--	--	--
Interest Coverage	--	--	--	-81.94	-69.49	-21.85

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	0.01	0.02	0.05
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	332.89	439.26	348.98	803.48	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.